Arab News,
Thu, Nov 21, 2024 | Jumada al-Awwal 19, 1446
Japan, Saudi medical centers unite to revolutionize stem cell therapy
Saudi Arabia:
Cytori Therapeutics Japan and the King Abdullah
International Medical Research Center have signed a Memorandum of Understanding
to strengthen research and training initiatives in the field of cell therapy.
The signing ceremony took place between Dr. Ahmed
Alaskar, executive director of KAIMRC, and Hoshino Yoshihiro, president and CEO
of Cytori Therapeutics K.K., during the Riyadh Global Medical Biotechnology
Summit 2024.
The partnership underscores the potential of
regenerative medicine in treating chronic diseases such as diabetes, liver
cirrhosis, critical limb ischemia, chronic wounds, knee osteoarthritis and other
aging-related conditions. The aim of combining Cytori’s cutting-edge stem cell
technology with KAIMRC’s expertise in translational research is to develop
groundbreaking treatments for these critical health issues.
The two organizations will collaborate on
fundamental research, clinical trials and other areas of mutual interest,
including projects in biomedical R&D, preclinical studies and clinical trials,
as well as training and development for staff in health-related and engineering
fields.
Cytori Therapeutics K.K., has been a pioneer in
the stem cell therapy business, specializing in cell therapy services and the
development of adipose-derived regenerative cells from human subcutaneous fat
tissues for therapeutic use. The company also develops, manufactures, and
exports medical devices.